Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Merck & Co. Inc. buy melinda

Merck & Co. Inc.
Start price
€57.58
20.10.17 / 50%
Target price
€59.53
20.04.18
Performance (%)
-6.62%
End price
€52.90
20.04.18
Summary
This prediction ended on 20.04.18 with a price of €52.90. With a performance of -6.62%, the BUY prediction for Merck & Co. Inc. by melinda closed slightly in the red. melinda has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Merck & Co. Inc. 2.529% 2.529% 20.872% 1.152%
iShares Core DAX® 0,02 % 0,58 % 11,67 % 61,62 %
iShares Nasdaq 100 1,74 % -2,06 % 4,18 % 88,71 %
iShares Nikkei 225® 0,43 % 10,49 % 29,99 % 67,05 %
iShares S&P 500 1,33 % 0,14 % 3,33 % 60,86 %

According to melinda what are the pros and cons of Merck & Co. Inc. for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Cons

Comments by melinda for this prediction

In the thread Merck & Co. Inc. diskutieren
Prediction Buy
Perf. (%) -6.62%
Target price 59.532
Change
Ends at 20.04.18

PHARMA



Firmenprofil
Merck and Company spezialisiert auf die Entwicklung unter Rezept verkauft, Herstellung und Vermarktung von therapeutischen Produkten und Impfstoffen. Der Umsatz ist Aktivität gliedern sich wie folgt: - Verkauf von pharmazeutischen Erzeugnissen (73,8%): für die Behandlung von Bluthochdruck



LYNPARZA hat das Potenzial , eine neue Behandlungsoption für Patienten mit metastasierendem HER2-negativen metastasierendem Brustkrebs bieten



melinda 
0
Report Share
20.10.17
Prediction Buy
Perf. (%) -6.62%
Target price 59.532
Change
Ends at 20.04.18

(Laufzeit überschritten)

melinda 
0
Report Share
20.04.18

Stopped prediction by melinda for Merck & Co. Inc.

sell
Merck & Co. Inc.

Start price
Target price
Perf. (%)
€70.76
26.10.21
€65.00
26.10.22
38.64%
27.10.22

Could be worthwhile Investment >10% per year
melinda 
26.10.21 50%
buy
Merck & Co. Inc.

Start price
Target price
Perf. (%)
€71.50
01.03.19
€77.00
04.11.21
-1.04%
26.10.21

Could be worthwhile Investment >10% per year
melinda 
18.08.19 50%
buy
Merck & Co. Inc.

Start price
Target price
Perf. (%)
€63.84
20.10.17
€66.00
20.04.18
-6.62%
20.04.18

Could be worthwhile Investment >10% per year
melinda 
14.08.19 50%
buy
Merck & Co. Inc.

Start price
Target price
Perf. (%)
€56.64
21.07.17
€59.53
14.09.17
5.90%
14.09.17

Could be worthwhile Investment >10% per year
melinda 
14.08.19 50%
buy
Merck & Co. Inc.

Start price
Target price
Perf. (%)
€62.79
21.07.17
€66.00
14.09.17
5.90%
14.09.17

Could be worthwhile Investment >10% per year
melinda 
14.08.19 50%